Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid receptor subunit delta (GABRD) is a protein that forms part of the heteropentameric GABA_A receptors, which are ligand-gated chloride channels activated by gamma-aminobutyric acid (GABA). Delta-containing GABA_A receptors mediate tonic inhibition, regulating neuronal excitability. They exhibit distinct pharmacology compared to synaptically localized receptors, showing high sensitivity to neurosteroids and ethanol, and low efficacy for direct activation by GABA. Mutations in GABRD have been associated with generalized epilepsy with febrile seizures type 5.
Forms part of heteropentameric GABA_A receptors, ligand-gated chloride channels activated by GABA, mediating tonic inhibition and regulating neuronal excitability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit delta (GABRD).